Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedTwo new recruitment sites were added: Uniwersyteckie Centrum Kliniczne, O?rodek Bada? Klinicznych Wczesnych Faz in Gdańsk, Poland, and IRST - PPDS in Meldola, Emilia-Romagna, Italy, expanding the study's geographic footprint. The page now indicates 76 locations.SummaryDifference0.3%

- Check20 days agoChange DetectedThe page’s revision version label was updated from v3.5.2 to v3.5.3, indicating an internal update to the ClinicalTrials.gov page build rather than a change to the study record content.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Hospital Universitario Puerta de Hierro - Majadahonda in Madrid as a recruiting site, bringing the total locations to 74. Updated the Padova site spelling from Padua to Padova and adjusted recruitment statuses across locations to reflect current activity.SummaryDifference0.3%

- Check55 days agoChange DetectedNapoli, Campania, Italy 80131 was replaced with Naples, Campania, Italy 80131, and a Naples site was added. The study revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedRecruitment-related statuses were removed on 2026-02-02 and 2026-01-30. New statuses Completed and Withdrawn were added on 2026-03-03, reflected in revision v3.4.3.SummaryDifference0.2%

Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.